Apr 17, 2018
Phenotypic screening is transforming drug discovery as advances are made in development of human-based physiologically-relevant in vitro systems.
Integration of phenotypic drug discovery approaches with target-based screening can improve success rates as assays can be leveraged for the discovery of novel mechanisms and for building knowledge of disease biology.
The article was written by Dr Ellen L. Berg who is Chief Scientific Officer at DiscoverX
If you'd like to view the original article then follow the link below:
You can also download the original article pdf here:
For more information on Drug Discovery World, head to: